{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:55:02Z","timestamp":1781830502051,"version":"3.54.5"},"reference-count":66,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,6]],"date-time":"2027-05-06T00:00:00Z","timestamp":1809561600000},"content-version":"am","delay-in-days":370,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R56AI146434"],"award-info":[{"award-number":["R56AI146434"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI162670"],"award-info":[{"award-number":["R01AI162670"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ymthe.2026.01.042","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:34:14Z","timestamp":1770078854000},"page":"3003-3022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intranasal unadjuvanted PspA spikes lung-resident memory immunity after parenteral pneumococcal vaccination"],"prefix":"10.1016","volume":"34","author":[{"given":"Saugata","family":"Majumder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreya","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd","family":"Saqib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayley","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Bissell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0071-6987","authenticated-orcid":false,"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.01.042_bib2","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Troeger","year":"2018","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.ymthe.2026.01.042_bib3","doi-asserted-by":"crossref","first-page":"979","DOI":"10.15585\/mmwr.mm7236a2","article-title":"Health Care Provider Knowledge and Attitudes Regarding Adult Pneumococcal Conjugate Vaccine Recommendations - United States, September 28-October 10, 2022","volume":"72","author":"Kahn","year":"2023","journal-title":"Mmwr-Morbid Mortal W"},{"key":"10.1016\/j.ymthe.2026.01.042_bib4","unstructured":"https:\/\/www.cdc.gov\/pinkbook\/hcp\/table-of-contents\/chapter-17-pneumococcal-disease.html."},{"key":"10.1016\/j.ymthe.2026.01.042_bib5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/infdis\/jit008","article-title":"Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia","volume":"207","author":"Fleming-Dutra","year":"2013","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.01.042_bib6","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/CMR.00058-05","article-title":"Insights into the interaction between influenza virus and pneumococcus","volume":"19","author":"McCullers","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.ymthe.2026.01.042_bib7","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ymthe.2026.01.042_bib8","series-title":"Antimicrobial Resistance in the 21st Century","first-page":"13","article-title":"Antimicrobial Resistance Among Streptococcus pneumoniae","author":"Cill\u00f3niz","year":"2018"},{"key":"10.1016\/j.ymthe.2026.01.042_bib9","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1097\/MJT.0000000000000551","article-title":"Antimicrobial Resistant Streptococcus pneumoniae: Prevalence, Mechanisms, and Clinical Implications","volume":"24","author":"Cherazard","year":"2017","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ymthe.2026.01.042_bib10","unstructured":"https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed."},{"key":"10.1016\/j.ymthe.2026.01.042_bib11","article-title":"Magnetic bead-based separation of pneumococcal serotypes","volume":"3","author":"York","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.ymthe.2026.01.042_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.resinv.2024.12.007","article-title":"Pneumococcal vaccines for prevention of adult pneumonia","volume":"63","author":"Morimoto","year":"2025","journal-title":"Respir. Investig."},{"key":"10.1016\/j.ymthe.2026.01.042_bib13","article-title":"Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines","volume":"9","author":"Scott","year":"2021","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.ymthe.2026.01.042_bib14","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1016\/j.vaccine.2017.10.076","article-title":"Safety and immunogenicity of a novel multiple antigen pneumococcal vaccine in adults: A Phase 1 randomised clinical trial","volume":"35","author":"Entwisle","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.01.042_bib15","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1016\/j.vaccine.2015.06.078","article-title":"Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled study","volume":"33","author":"Brooks","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.01.042_bib16","article-title":"Preliminary Evaluation of the Safety and Immunogenicity of a Novel Protein-Based Pneumococcal Vaccine in Healthy Adults Aged 18-49: A Phase Ia Randomized, Double Blind, Placebo-Controlled Clinical Study","volume":"12","author":"Wang","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2026.01.042_bib17","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1016\/j.vaccine.2013.07.049","article-title":"A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA","volume":"31","author":"Frey","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.01.042_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41541-024-01033-5","article-title":"Intranasal influenza-vectored vaccine expressing pneumococcal surface protein A protects against Influenza and Streptococcus pneumoniae infections","volume":"9","author":"Cardoso","year":"2024","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.ymthe.2026.01.042_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202307066","article-title":"Pneumonic Plague Protection Induced by a Monophosphoryl Lipid A Decorated Yersinia Outer-Membrane-Vesicle Vaccine","volume":"20","author":"Majumder","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.ymthe.2026.01.042_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.mucimm.2024.01.002","article-title":"A bacterial vesicle-based pneumococcal vaccine against influenza-mediated secondary Streptococcus pneumoniae pulmonary infection","volume":"17","author":"Majumder","year":"2024","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib21","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2357924","article-title":"4CMenB journey to the 10-year anniversary and beyond","volume":"20","author":"Abitbol","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2026.01.042_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s40259-023-00627-0","article-title":"Outer Membrane Vesicle Vaccine Platforms","volume":"38","author":"Micoli","year":"2024","journal-title":"BioDrugs."},{"key":"10.1016\/j.ymthe.2026.01.042_bib23","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.1128\/IAI.68.10.5889-5900.2000","article-title":"Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae","volume":"68","author":"Hollingshead","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2026.01.042_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/JCI166827","article-title":"Intranasal immunization with an RBD-hemagglutinin fusion protein harnesses preexisting immunity to enhance antigen-specific responses","volume":"133","author":"Kawai","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.01.042_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/science.abo2523","article-title":"Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses","volume":"378","author":"Mao","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.ymthe.2026.01.042_bib26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-015-0350-4","article-title":"Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs","volume":"38","author":"Petrovsky","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.ymthe.2026.01.042_bib27","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1080\/21645515.2016.1239668","article-title":"Current prospects and future challenges for nasal vaccine delivery","volume":"13","author":"Yusuf","year":"2017","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ymthe.2026.01.042_bib28","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.vaccine.2016.12.055","article-title":"Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain","volume":"35","author":"Caro-Aguilar","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.01.042_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.vaccine.2004.05.035","article-title":"Influenza and pneumococcal vaccination as a model to assess C-reactive protein response to mild inflammation","volume":"23","author":"Posthouwer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.ymthe.2026.01.042_bib30","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1128\/jb.90.6.1520-1524.1965","article-title":"Mouse C-reactive protein and endotoxin-induced resistance","volume":"90","author":"Patterson","year":"1965","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib31","article-title":"Evaluation of Pneumococcal Surface Protein A as a Vaccine Antigen against Secondary Streptococcus pneumoniae Challenge during Influenza A Infection","volume":"7","author":"Roberts","year":"2019","journal-title":"Vaccines (Basel)."},{"key":"10.1016\/j.ymthe.2026.01.042_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1099\/jmm.0.46268-0","article-title":"Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries","volume":"55","author":"Hollingshead","year":"2006","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1128\/CVI.00430-09","article-title":"Immunization of Mice with Single PspA Fragments Induces Antibodies Capable of Mediating Complement Deposition on Different Pneumococcal Strains and Cross-Protection","volume":"17","author":"Moreno","year":"2010","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib34","doi-asserted-by":"crossref","first-page":"4518","DOI":"10.1128\/IAI.00486-09","article-title":"PspA family fusion proteins delivered by attenuated Salmonella enterica serovar Typhimurium extend and enhance protection against Streptococcus pneumoniae","volume":"77","author":"Xin","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2026.01.042_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141810","article-title":"Lung-resident memory B cells protect against bacterial pneumonia","volume":"131","author":"Barker","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.01.042_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nprot.2014.005","article-title":"Intravascular staining for discrimination of vascular and tissue leukocytes","volume":"9","author":"Anderson","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ymthe.2026.01.042_bib37","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.1073\/pnas.0501254102","article-title":"CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization","volume":"102","author":"Malley","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.042_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.4049\/jimmunol.2200487","article-title":"Lung Resident Memory T Cells Activated by Oral Vaccination Afford Comprehensive Protection against Pneumonic Yersinia pestis Infection","volume":"210","author":"Singh","year":"2023","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41385-021-00461-z","article-title":"Tissue resident memory T cells in the respiratory tract","volume":"15","author":"Zheng","year":"2022","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nri.2015.3","article-title":"Tissue-resident memory T cells: local specialists in immune defence","volume":"16","author":"Mueller","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib41","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20011576","article-title":"The immune response to pneumococcal proteins during experimental human carriage","volume":"195","author":"McCool","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ymthe.2026.01.042_bib42","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mi.2014.95","article-title":"Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses","volume":"8","author":"Wilson","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154616","article-title":"Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae","volume":"11","author":"Kristian","year":"2016","journal-title":"Plos One"},{"key":"10.1016\/j.ymthe.2026.01.042_bib44","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4615-1823-5_7","article-title":"A compendium of vaccine adjuvants and excipients","volume":"6","author":"Vogel","year":"1995","journal-title":"Pharm. Biotechnol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib45","article-title":"Meningococcal Vaccines: Current Status and Emerging Strategies","volume":"6","author":"McCarthy","year":"2018","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.ymthe.2026.01.042_bib46","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.chom.2021.10.001","article-title":"Mice with diverse microbial exposure histories as a model for preclinical vaccine testing","volume":"29","author":"Fiege","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2026.01.042_bib47","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/21645515.2020.1780092","article-title":"Outer membrane vesicles: moving within the intricate labyrinth of assays that can predict risks of reactogenicity in humans","volume":"17","author":"Rossi","year":"2021","journal-title":"Hum. Vacc Immunother."},{"key":"10.1016\/j.ymthe.2026.01.042_bib48","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib49","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add4853","article-title":"Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination","volume":"7","author":"Tang","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib50","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1016\/j.ymthe.2024.10.016","article-title":"Enhanced mucosal SARS-CoV-2 immunity after heterologous intramuscular mRNA prime\/intranasal protein boost vaccination with a combination adjuvant","volume":"32","author":"Laghlali","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.01.042_bib51","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ymthe.2026.01.042_bib52","doi-asserted-by":"crossref","first-page":"5930","DOI":"10.1128\/IAI.00940-07","article-title":"Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition","volume":"75","author":"Darrieux","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2026.01.042_bib53","article-title":"Pneumococcal Surface Proteins as Virulence Factors, Immunogens, and Conserved Vaccine Targets","volume":"12","author":"Aceil","year":"2022","journal-title":"Front Cell Infect Mi"},{"key":"10.1016\/j.ymthe.2026.01.042_bib54","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.smim.2018.05.003","article-title":"Antibody glycosylation in inflammation, disease and vaccination","volume":"39","author":"Alter","year":"2018","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib55","doi-asserted-by":"crossref","DOI":"10.1172\/JCI179563","article-title":"Pathobiont-driven antibody sialylation through IL-10 undermines vaccination","volume":"134","author":"Tsai","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ymthe.2026.01.042_bib56","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1128\/IAI.72.9.5031-5040.2004","article-title":"PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin [corrected]","volume":"72","author":"Shaper","year":"2004","journal-title":"Infect. Immun."},{"key":"10.1016\/j.ymthe.2026.01.042_bib57","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1128\/CVI.00395-08","article-title":"Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice","volume":"16","author":"Ferreira","year":"2009","journal-title":"Clin. Vaccin. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib58","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.4049\/jimmunol.1701065","article-title":"Nasopharyngeal Exposure to Streptococcus pneumoniae Induces Extended Age-Dependent Protection against Pulmonary Infection Mediated by Antibodies and CD138(+) Cells","volume":"200","author":"Bou Ghanem","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib59","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/mi.2017.43","article-title":"Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia","volume":"11","author":"Smith","year":"2018","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib60","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1016\/j.immuni.2023.08.015","article-title":"Interferon-y production by Tfh cells is required for CXCR3+pre-memory B cell differentiation and subsequent lung-resident memory B cell responses","volume":"56","author":"Arroyo-D\u00edaz","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.ymthe.2026.01.042_bib61","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41590-025-02156-0","article-title":"Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice","volume":"26","author":"Kwon","year":"2025","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1382638","article-title":"B cells in the pneumococcus-infected lung are heterogeneous and require CD4(+) T cell help including CD40L to become resident memory B cells","volume":"15","author":"Etesami","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ymthe.2026.01.042_bib63","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chom.2021.12.004","article-title":"Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses","volume":"30","author":"Tauzin","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ymthe.2026.01.042_bib64","article-title":"Remodeling Yersinia pseudotuberculosis to generate a highly immunogenic outer membrane vesicle vaccine against pneumonic plague","volume":"119","author":"Wang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.042_bib65","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01335-19","article-title":"Allergic Airway Disease Prevents Lethal Synergy of Influenza A Virus-Streptococcus pneumoniae Coinfection","volume":"10","author":"Roberts","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.ymthe.2026.01.042_bib66","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2110166119","article-title":"Hemochromatosis drives acute lethal intestinal responses to hyperyersiniabactin-producing Yersinia pseudotuberculosis","volume":"119","author":"Das","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymthe.2026.01.042_bib67","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00699-21","article-title":"Outer Membrane Vesicles Displaying a Heterologous PcrV-HitA Fusion Antigen Promote Protection against Pulmonary Pseudomonas aeruginosa Infection","volume":"6","author":"Li","year":"2021","journal-title":"Msphere"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626000857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:35:52Z","timestamp":1781829352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626000857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":66,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1525001626000857"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.042","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal unadjuvanted PspA spikes lung-resident memory immunity after parenteral pneumococcal vaccination","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.01.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}